Pitavastatin-d5 Sodium Salt

CAS: 147511-69-1

Ref. TR-P531007

Produktinformation

• Name: Pitavastatin-d5 Sodium Salt
• Synonyme: (3R,5S,6E)-7-[2-(Cyclopropyl-d5)-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt, (+)-(3R,5S,6E)-7-[2-(Cyclopropyl-d5)-4-(4-fluorophenyl)-3-quinolyl] -3,5-dihydroxy-6-heptenoic Acid Sodium Salt, NK 104-d5 Sodium Salt, (+)-(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoic acid, (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid, (3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid, (6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid, 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, (3R,5S,6E)-, 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, [S-[R*,S*-(E)]]-, Itavastatin, Monocalciumbis{(3R,5S,6E)-7-[2-Cyclopyl-4-(4-Fluorophenyl)-3-Quinolyl]-3,5-Dihydroxy-6-Heptenoate}, Nk 104, Pitavastatin Acid, Pitvastatin

Beschreibung

Applications Labelled Pitavastatin. A HMG CoA reductase inhibitor. An antilipemic.
References Yen, H., et al.: J. Clin. Invest., 98, 1253 (1996), Zou, Y., et al.: J. Biol. Chem., 274, 9760 (1999), Sun, X., et al.: Cancer Res., et al.: 61, 3382 (2001), Ladas, E.J., et al.: Clin. Oncol., 22, 517 (2004),

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 448.47
• Formel: C₂₅H₁₈D₅FNNaO₄
• Farbe/Form: Neat
• InChl: InChI=1S/C25H24FNO4.Na/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;+1/p-1/b12-11+;/t18-,19-;/m1./s1/i5D2,6D2,16D
• InChI Key: InChIKey=NBDQGOCGYHMDSJ-JVDMFWQQSA-M
• SMILES: [2H]C1([2H])C([2H])([2H])C1([2H])c1nc2ccccc2c(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O[Na]